NAFLD, NASH and liver cancer
- PMID: 24080776
- DOI: 10.1038/nrgastro.2013.183
NAFLD, NASH and liver cancer
Abstract
NAFLD affects a large proportion of the US population and its incidence and prevalence are increasing to epidemic proportions around the world. As with other liver diseases that cause cirrhosis, NAFLD increases the risk of liver cancer, a disease with poor outcomes and limited therapeutic options. The incidences of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma are also rising, and HCC is now the leading cause of obesity-related cancer deaths in middle-aged men in the USA. In this Review, we summarize the correlations between liver cancer and NAFLD-related cirrhosis, and the role of the metabolic syndrome in the development of liver cancer from diverse aetiologies, including HCV-mediated cirrhosis. Recent advances in understanding the progression of NAFLD to HCC from preclinical models will also be discussed. Targeted genetic manipulation of certain metabolic or stress-response pathways, including one-carbon metabolism, NF-κB, PTEN and microRNAs, has been valuable in elucidating the pathways that regulate carcinogenesis in NAFLD. Although tremendous advances have occurred in the identification of diagnostic and therapeutic opportunities to reduce the progression of NAFLD, considerable gaps in our knowledge remain with regard to the mechanisms by which NAFLD and its risk factors promote liver cancer.
Similar articles
-
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103. World J Gastroenterol. 2015. PMID: 25892859 Free PMC article. Review.
-
Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC.Int J Mol Sci. 2021 Apr 26;22(9):4495. doi: 10.3390/ijms22094495. Int J Mol Sci. 2021. PMID: 33925827 Free PMC article. Review.
-
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525. Int J Mol Sci. 2020. PMID: 32102237 Free PMC article. Review.
-
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.Indian J Med Res. 2019 Jan;149(1):9-17. doi: 10.4103/ijmr.IJMR_1456_17. Indian J Med Res. 2019. PMID: 31115369 Free PMC article. Review.
-
Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:88-92. doi: 10.1111/jgh.12239. J Gastroenterol Hepatol. 2013. PMID: 24251711 Review.
Cited by
-
Carcinogenetic initiation contributed by EpCAM+ cancer cells in orthotopic HCC models of immunocompetent and athymic mice.Oncotarget. 2020 Jun 2;11(22):2047-2060. doi: 10.18632/oncotarget.27454. eCollection 2020 Jun 2. Oncotarget. 2020. PMID: 32547703 Free PMC article.
-
Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease.Am J Physiol Gastrointest Liver Physiol. 2015 May 1;308(9):G794-803. doi: 10.1152/ajpgi.00390.2014. Epub 2015 Mar 6. Am J Physiol Gastrointest Liver Physiol. 2015. PMID: 25747354 Free PMC article.
-
Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice.Front Pharmacol. 2022 Aug 19;13:934136. doi: 10.3389/fphar.2022.934136. eCollection 2022. Front Pharmacol. 2022. PMID: 36059948 Free PMC article.
-
Associations of multiple toxic metal exposures with metabolic dysfunction-associated fatty liver disease: NHANES 2011-2018.Front Nutr. 2023 Dec 4;10:1301319. doi: 10.3389/fnut.2023.1301319. eCollection 2023. Front Nutr. 2023. PMID: 38115883 Free PMC article.
-
Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease.J Clin Invest. 2015 Mar 2;125(3):981-92. doi: 10.1172/JCI73957. Epub 2015 Jan 26. J Clin Invest. 2015. PMID: 25621497 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials